A Phase 1, Placebo-Controlled, Randomized Study Evaluating the Safety and Pharmacokinetics of GS-4059 in Healthy Volunteers and Subjects With Rheumatoid Arthritis (RA)
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Tirabrutinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Gilead Sciences
- 28 Sep 2016 Status changed from active, no longer recruiting to completed.
- 19 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 12 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.